Drug Search Results
More Filters [+]

Dienestrol

Alternative Names: dienestrol, dv, estraguard
Latest Update: 2024-12-17
Latest Update Note: News Article

Product Description

Mechanisms of Action: ER Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Subcutaneous

FDA Designation: None *

Approval Status: Approved

Approved Countries: Australia | Canada | Colombia | Germany | India | Ireland | New Zealand | Pakistan | Peru | Poland | Portugal | Slovenia | Taiwan

Approved Indications: None

Known Adverse Events: None

Company: PrimeVax Immuno-Oncology
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Dienestrol

Countries in Clinic: China

Active Clinical Trial Count: 5

Highest Development Phases

Phase 3: Adenocarcinoma|Esophageal Cancer|Gastrointestinal Cancer

Phase 2: Non-Small-Cell Lung Cancer|Prostate Cancer

Phase 1: Melanoma

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

RC48-C035

P3

Recruiting

Adenocarcinoma|Esophageal Cancer|Gastrointestinal Cancer

2026-12-01

RC48-C021

P2

Not yet recruiting

Non-Small-Cell Lung Cancer

2025-12-01

RC48-C034

P2

Recruiting

Prostate Cancer

2025-12-01

PV001-001 (Arm 2)

P1

Not yet recruiting

Melanoma

2024-09-30

27%

Recent News Events